
Science-based health care from head to toe: Mycellen receives a 50 million HUF investment from OUVC
Mycellen Supplements, one of the most promising Hungarian players in biotechnology-driven health and beauty care, has received a 50 million forint investment from Obuda Uni Venture Capital. The capital increase aims to strengthen the company’s market presence, expand its product portfolio, and increase awareness of science-based, prevention-focused beauty and health care through more prominent communication.








